Xeomin

Xeomin is a prescription neurotoxin derived from Clostridium Botulinum Type A, free of complexing proteins, used for intramuscular and intraglandular applications. It is indicated for temporary muscle relaxation and glandular hyperactivity. This product is manufactured by Merz Pharmaceuticals GmbH and distributed in the EU.

Xeomin is commonly used to address conditions involving muscle overactivity or glandular hyperfunction. It is often employed for aesthetic purposes, such as reducing the appearance of dynamic wrinkles, as well as for medical indications like cervical dystonia, blepharospasm, and sialorrhea. The product works by temporarily blocking nerve signals to targeted muscles or glands.

Users may notice a gradual reduction in muscle tightness or glandular secretion following treatment with Xeomin. The effects typically become noticeable within a few days and can last for several months. Individual responses may vary based on the treated area and the condition being addressed.

Xeomin should only be administered by a qualified healthcare professional experienced in the use of injectable neurotoxins. Patients with known allergies to botulinum toxin or human albumin should avoid this product. Temporary side effects like redness, swelling, or bruising at the injection site are common but usually resolve quickly.

Concomitant use of Xeomin with other muscle relaxants, aminoglycoside antibiotics, or medications affecting neuromuscular transmission may increase the risk of systemic effects. Alcohol and other substances that may affect muscle activity should be used with caution around the time of treatment. Always inform your provider about all medications and supplements being taken.